MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

NCT04874506 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Glioblastoma Multiforme

Interventions

DRUG: MBM-02

Sponsor

Matrix Biomed, Inc.

Collaborators

[object Object]